Yang VC - Search Results

1

Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery.

Huang Y, Jiang Y, Wang H, Wang J, Shin MC, Byun Y, He H, Liang Y, Yang VC. Huang Y, et al. Among authors: yang vc. Adv Drug Deliv Rev. 2013 Oct;65(10):1299-315. doi: 10.1016/j.addr.2012.11.007. Epub 2013 Jan 28. Adv Drug Deliv Rev. 2013. PMID: 23369828 Free PMC article. Review.

2

Optimization and assessment of the in vivo efficacy of a heparin removing bio-reactor using mathematical modeling.

Byun Y, Wang T, Kim JS, Yang VC. Byun Y, et al. Among authors: yang vc. ASAIO J. 1996 Sep-Oct;42(5):M782-7. doi: 10.1097/00002480-199609000-00096. ASAIO J. 1996. PMID: 8944989

3

Delivery system for targeted thrombolysis without the risk of hemorrhage.

Byun Y, Yang VC. Byun Y, et al. Among authors: yang vc. ASAIO J. 1998 Sep-Oct;44(5):M638-41. doi: 10.1097/00002480-199809000-00068. ASAIO J. 1998. PMID: 9804513

4

A recombinant prodrug type approach for triggered delivery of streptokinase.

Wang H, Song H, Yang VC. Wang H, et al. Among authors: yang vc. J Control Release. 1999 May 1;59(1):119-22. doi: 10.1016/s0168-3659(99)00019-x. J Control Release. 1999. PMID: 10210728

5

Low molecular weight protamine: a potential nontoxic heparin antagonist.

Byun Y, Singh VK, Yang VC. Byun Y, et al. Among authors: yang vc. Thromb Res. 1999 Apr 1;94(1):53-61. doi: 10.1016/s0049-3848(98)00201-1. Thromb Res. 1999. PMID: 10213181

6

Low molecular weight protamine: a potent but nontoxic antagonist to heparin/low molecular weight protamine.

Byun Y, Chang LC, Lee LM, Han IS, Singh VK, Yang VC. Byun Y, et al. Among authors: yang vc. ASAIO J. 2000 Jul-Aug;46(4):435-9. doi: 10.1097/00002480-200007000-00013. ASAIO J. 2000. PMID: 10926141

7

ATTEMPTS: a heparin/protamine-based triggered release system for the delivery of enzyme drugs without associated side-effects.

Park YJ, Liang JF, Song H, Li YT, Naik S, Yang VC. Park YJ, et al. Among authors: yang vc. Adv Drug Deliv Rev. 2003 Feb 10;55(2):251-65. doi: 10.1016/s0169-409x(02)00181-3. Adv Drug Deliv Rev. 2003. PMID: 12564979 Review.

8

Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics.

Chertok B, David AE, Huang Y, Yang VC. Chertok B, et al. Among authors: yang vc. J Control Release. 2007 Oct 8;122(3):315-23. doi: 10.1016/j.jconrel.2007.05.030. Epub 2007 Jun 2. J Control Release. 2007. PMID: 17628157 Free PMC article.

9

The ATTEMPTS delivery systems for macromolecular drugs.

Kwon YM, Li Y, Naik S, Liang JF, Huang Y, Park YJ, Yang VC. Kwon YM, et al. Among authors: yang vc. Expert Opin Drug Deliv. 2008 Nov;5(11):1255-66. doi: 10.1517/17425240802498059. Expert Opin Drug Deliv. 2008. PMID: 18976135 Review.

10

The artificial peroxidase activity of magnetic iron oxide nanoparticles and its application to glucose detection.

Yu F, Huang Y, Cole AJ, Yang VC. Yu F, et al. Among authors: yang vc. Biomaterials. 2009 Sep;30(27):4716-22. doi: 10.1016/j.biomaterials.2009.05.005. Epub 2009 Jun 9. Biomaterials. 2009. PMID: 19515418 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters